Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E14.74 EPS (ttm)3.74 Insider Own- Shs Outstand2.43B Perf Week5.39%
Market Cap133.73B Forward P/E14.02 EPS next Y3.93 Insider Trans- Shs Float2.43B Perf Month4.06%
Income9.14B PEG1.59 EPS next Q- Inst Own10.50% Short Float0.26% Perf Quarter2.07%
Sales44.54B P/S3.00 EPS this Y22.50% Inst Trans0.00% Short Ratio2.54 Perf Half Y10.79%
Book/sh4.89 P/B11.28 EPS next Y10.01% ROA17.70% Target Price61.13 Perf Year13.01%
Cash/sh3.87 P/C14.26 EPS next 5Y9.30% ROE114.20% 52W Range46.60 - 56.60 Perf YTD4.67%
Dividend3.00 P/FCF43.37 EPS past 5Y4.60% ROI24.90% 52W High-2.58% Beta0.63
Dividend %5.44% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin69.80% 52W Low18.33% ATR0.82
Employees99451 Current Ratio1.10 Sales Q/Q1.50% Oper. Margin28.20% RSI (14)60.99 Volatility0.92% 1.05%
OptionableYes Debt/Eq2.61 EPS Q/Q191.40% Profit Margin28.00% Rel Volume0.90 Prev Close55.30
ShortableYes LT Debt/Eq2.21 EarningsFeb 03 Payout68.60% Avg Volume2.47M Price55.14
Recom2.60 SMA204.11% SMA501.70% SMA2006.77% Volume2,215,069 Change-0.29%
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
25-May-07Reiterated Banc of America Sec Neutral $62 → $57
23-Apr-14 06:10PM  Epizyme Up on Milestone Payment from Glaxo Zacks
05:40PM  Novartis Signs Deals With GlaxoSmithKline & Eli Lilly Zacks
03:46PM  Novartis, GlaxoSmithKline Exchange Boosts Both Companies' Stocks, 2014 Outlook at Seeking Alpha
11:14AM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
11:05AM  [video] Deal Flurry Shows Drug Makers Move to Specialization at MarketWatch
10:51AM  GlaxoSmithKline plc Gives Up On Cancer at Motley Fool
10:43AM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
10:11AM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
09:10AM  Will This Analyst Upgrade Help GlaxoSmithKline (GSK) Today? at TheStreet
08:14AM  GlaxoSmithKline upgraded by Argus Briefing.com
05:58AM  GlaxoSmithKline plc's Dividends Set To Reach 5.4%! at Motley Fool
01:32AM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
12:20AM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
12:08AM  Asia shares mixed on lackluster China data AP
22-Apr-14 11:00PM  Asia shares mixed after HSBC China flash PMI; Japan's Seibu rallies at CNBC
10:14PM  Asia shares mixed after HSBC China flash PMI; Japan's Seibu rallies at CNBC
09:00PM  Asia shares gain ahead of HSBC China flash PMI at CNBC
08:53PM  [$$] Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands at The Wall Street Journal
08:21PM  Asia shares gain ahead of HSBC China flash PMI at CNBC
06:36PM  Drugmakers Prod European Stocks To Post-Easter Rally at Investor's Business Daily
06:27PM  Deals bubble up in big pharma at USA TODAY
06:01PM  Stocks close higher as S&P 500 rises for 6th day at USA TODAY
05:50PM  Drug M&A Revives In Drive To Expand, But Also To Focus Investor's Business Daily
05:15PM  Deals bubble up in big pharma at USA TODAY
05:15PM  Stocks Rise In Higher Volume; Gilead Up After Hours at Investor's Business Daily
04:29PM  Stocks close higher as S&P 500 rises for 6th day at USA TODAY
04:29PM  S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up at Investor's Business Daily
04:24PM  Earnings and big pharma deals drive stocks up Hot Stock Minute
02:38PM  Big Pharma Seeking to Reduce Risk, Boost Profits Thru Deals at Fox Business
01:40PM  Is This a Good Deal for Novartis AG and GlaxoSmithKline plc? at Motley Fool
12:48PM  Glaxo Deals Shift Focus to Vaccines, Consumer Products at Bloomberg
12:37PM  Spring Fever? Novartis, GlaxoSmithKline, and Eli Lillys Deal-Making Frenzy at Wall St. Cheat Sheet
12:09PM  [video] Making Sense of Novartis and GlaxoSmithKline's Web of Deals at TheStreet
12:02PM  [video] Pharma's big deal frenzy at CNBC
11:50AM  Allergan Bid Adds to Flurry of Pharmaceutical Deals at New York Times
11:49AM  Novartis, Glaxo Swap Units; Lilly Buying Animal Biz at Investor's Business Daily
11:41AM  GlaxoSmithKline plc's Short-Term Pain Could Be Investors' Long-Term Gain at Motley Fool
10:13AM  [$$] Deals Reshape Novartis, Glaxo at The Wall Street Journal
09:50AM  Big pharma deals signal next phase of growth Hot Stock Minute
09:39AM  Novartis reshapes business with GSK, Lilly deals AP
09:30AM  [$$] Deals Reshape Novartis, Glaxo at The Wall Street Journal
09:23AM  Can GlaxoSmithKline PLC Rule The World? at Motley Fool
09:06AM  With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies at Forbes
09:02AM  Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis AG, and Gilead Sciences, Inc. at Motley Fool
08:57AM  Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb at Investor's Business Daily
08:45AM  GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan Marketwired
08:30AM  [$$] Deals Reshape Novartis, Glaxo at The Wall Street Journal
08:19AM  [$$] Glaxo Exits Cancer Drugs at The Wall Street Journal
08:14AM  [$$] Deals Reshape Novartis, Glaxo at The Wall Street Journal
08:13AM  Why GlaxoSmithKline (GSK) Stock Is Higher This Morning at TheStreet
08:10AM  Glaxo, Novartis, Eli Lilly in 'major 3-part' deal at USA TODAY
08:06AM  Why cancer drug newcomer GSK is getting out: CEO at CNBC
08:06AM  Drug deal is key for vaccines: GlaxoSmithkline CEO at CNBC
07:49AM  [$$] Glaxo Exits Cancer Drugs at The Wall Street Journal
07:43AM  [video] European Markets Recover, On a Dose of Pharmaceuticals at TheStreet
07:37AM  Big moves in Pharma; McDonald's earnings; Gas prices on the rise Hot Stock Minute
07:25AM  3-way drug deal benefits all: GlaxoSmithkline CEO at CNBC
07:23AM  Novartis Buys Glaxo Cancer Drugs for $16B, Sells Animal Health, Vaccines in CEO Jimenez's Biggest Shakeup Bloomberg
06:45AM  [video] Novartis acquisition adds 'tremendous value' at CNBC
06:45AM  [video] GlaxoSmithKline CEO: Widest portfolio of vaccines in world at CNBC
05:43AM  European Markets Gain; Drug-Makers in Focus Morningstar
05:36AM  [$$] Big Brands Unite in Novartis, GlaxoSmithKline Consumer-Health Joint Venture at The Wall Street Journal
05:28AM  [$$] Big Brands Unite in Novartis, GlaxoSmithKline Consumer-Health Joint Venture at The Wall Street Journal
05:23AM  Novartis divests Vaccines business to GSK for $7.1B theflyonthewall.com
05:12AM  Novartis Buys Glaxo Cancer Drugs for $16B, Sells Animal Health, Vaccines in CEO Jimenez's Biggest Shakeup Bloomberg
05:12AM  Novartis Buying Glaxo Cancer Unit for $16B, Selling Animal Health to Eli Lilly for $5.4B Bloomberg
04:50AM  Glaxo, Novartis, Eli Lilly in 'major 3-part' deal at USA TODAY
04:24AM  GlaxoSmithKline plc To Return £4bn To Shareholders at Motley Fool
03:46AM  GlaxoSmithKline says Novartis deal could lead to more disposals Reuters
03:15AM  Healthcare rises as Europe shares rally: M&A in focus at CNBC
03:08AM  Novartis Buying Glaxo Cancer Unit for $16B, Selling Animal Health to Eli Lilly for $5.4B Bloomberg
03:00AM  [video] Novartis, GSK deal 'win win': Pro at CNBC
02:34AM  Novartis to buy GlaxoSmithKline cancer unit for up to $16 billion at Los Angeles Times
02:18AM  Novartis Unveils Major Restructuring In a Flurry of Deals at New York Times
02:18AM  Novartis Announces Major Restructuring at New York Times
01:58AM  Novartis Buying Glaxo Cancer Unit for $16B, Selling Animal Health to Eli Lilly for $5.4B Bloomberg
01:52AM  Novartis, GSK join forces in joint venture at CNBC
01:17AM  Novartis to Buy Glaxo Cancer Drugs, Sell Animal Health at Bloomberg
01:12AM  Novartis, GSK to create joint venture; Novartis to pay up to $16 billion for GSK oncology products at CNBC
21-Apr-14 07:40PM  The Biggest Biotech Wins of the Week at Motley Fool
01:44PM  New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy at Seeking Alpha
18-Apr-14 02:16PM  In Case You Missed It: GlaxoSmithKline Just Had a Phenomenal Week! at Motley Fool
10:38AM  10 Of 17 Top Sin Stocks Stalk 7% To 22% Upsides at Seeking Alpha
17-Apr-14 06:40PM  Potential New Treatment for Alcoholism: Ezogabine at Forbes
05:35PM  Glaxo Looking into Misconduct Charges Zacks
05:24PM  GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate PR Newswire
01:04PM  GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD CNW Group
04:06AM  3 Reasons Why GlaxoSmithKline plc Is More Than Just A Great Income Stock at Motley Fool
12:42AM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
16-Apr-14 10:47PM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
08:40PM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
07:09PM  New Glaxo bribery inquiries Investor's Business Daily
06:48PM  Is Johnson & Johnson's Dividend Unbeatable? at Motley Fool
05:35PM  Glaxo's Tanzeum Approved in the U.S. Zacks
03:10PM  Dynavax Starts Phase III Study on Heplisav-B Zacks
02:28PM  Will Recent News Hurt GlaxoSmithKline? at Wall St. Cheat Sheet
01:38PM  Dear Jenny McCarthy, Here's How Many Lives Could Be Saved Cheaply By Making Vaccines More Widely Available at Forbes
01:32PM  [$$] Glaxo Examines Bribery Claims at The Wall Street Journal
12:26PM  GlaxoSmithKline discloses new bribery inquiries AP
12:25PM  GlaxoSmithKline discloses new bribery inquiries AP
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM
GLAXOSMITHKLINE PLC10% OwnerJul 30Buy111850855.503,064,407342,756,544,550,18929,785,600Aug 01 09:23 AM
GLAXOSMITHKLINE PLC10% OwnerApr 30Buy6699215.43193,5631,296,720,236,27726,721,193Apr 30 02:38 PM